Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
HS
Not CommonRésumée par IA
Hibiscus Sabdariffa
Hibiscus sabdariffa
hypertension dans la médecine traditionnelle égyptienne et mexicaine
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 29 articles PubMed · modèle : gemma4:31b
Résumé
Hibiscus sabdariffa (roselle) is a plant used traditionally in food and medicine, demonstrating potential effects on blood pressure, lipid profiles, and glucose levels [PMID:25038696, PMID:34927694].
Contexte
Hibiscus sabdariffa L., also known as roselle or karkade, is a perennial plant from the Malvaceae family grown in tropical and subtropical regions including China, Egypt, Indonesia, Mexico, Nigeria, Thailand, and Saudi Arabia [PMID:29597091, PMID:32354172].
Usages traditionnels
It has been used traditionally as a food, in herbal drinks (hot and cold), as a flavoring agent, and as a herbal medicine [PMID:25038696, PMID:32354172].
Composés actifs
Bioactive constituents include anthocyanins (such as delphinidin-3-sambubioside and cyanidin-3-sambubioside), polyphenols (protocatechuic acid, quercetin), flavonoids, polysaccharides, and organic acids (citric, hydroxycitric, hibiscus, tartaric, malic, and ascorbic) [PMID:25038696, PMID:29597091, PMID:32354172, PMID:27186114]. Seeds are also a source of gamma-tocopherol and fatty acids like linoleic and oleic acid [PMID:17995816, PMID:38432993].
Mécanisme d'action
Potential mechanisms include inhibition of angiotensin-converting enzymes (ACE), inhibition of α-glucosidase and α-amylase, direct vaso-relaxant effects, calcium channel modulation, and antioxidant activities [PMID:25038696]. It may also modulate the TLR4/MyD88/NF-κB and Caspase-11/NLRP3 inflammasome signaling pathways to reduce proinflammatory cytokines [PMID:40549318].
Preuves cliniques
Preuve AHypertension
Hibiscus exerted stronger effects on systolic blood pressure (-7.10 mmHg) than placebo, particularly in those with elevated baseline BP [PMID:34927694].
Preuve AHyperlipidemia
Supplementation significantly reduced total cholesterol and low-density lipoprotein cholesterol, though it did not effectively reduce triglycerides [PMID:31833112].
Preuve BPostprandial Glucose
Consumption of a hibiscus-containing beverage significantly reduced postprandial glucose response compared to placebo [PMID:40009760].
Preuve BSkin Aging
A plant-based collagen alternative (VC-H1 Hibiscus Enzyme Extract) significantly increased skin hydration and reduced wrinkles over 12 weeks [PMID:40806423].
Preuve DPhysical Fitness
Daily consumption of 200 ml roselle tea for 30 days significantly improved strength, balance, grip strength, and VO2max in healthy adults [PMID:38357241].
Preuve A
Sécurité et effets indésirables
Hibiscus is 'generally recognized as safe' (GRAS) as a food by the U.S. FDA and is generally well tolerated, although allergic reactions may occur, including cross-reactions with other Malvaceae family members like marshmallow or ambrette [PMID:30000942].
Grossesse et allaitement
While used as a galactogogue in some cultures, no scientifically valid clinical trials support this use, and no data exist on the safety or excretion of components into breastmilk [PMID:30000942].
Synthèse des preuves
Strong evidence (Meta-analyses) supports the use of Hibiscus sabdariffa for reducing systolic blood pressure and lowering total and LDL cholesterol. Evidence for glucose regulation and skin rejuvenation is emerging from clinical trials, while evidence for obesity treatment is currently inconclusive.
Sources PubMed
1.PMID: 25038696 (2014) — Hibiscus sabdariffa L. - a phytochemical and pharmacological review. · Food chemistry
2.PMID: 29597091 (2018) — A review on phytochemistry and therapeutic uses of Hibiscus sabdariffa L. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
3.PMID: 30000942 (2006) — Efficacy of Hibiscus sabdariffa on Reducing Blood Pressure in Patients With Mild-to-Moderate Hypertension: A Systematic Review and Meta-Analysis of Published Randomized Controlled Trials. · Journal of cardiovascular pharmacology
4.PMID: 34927694 (2022) — A systematic review and meta-analysis of the effects of Hibiscus sabdariffa on blood pressure and cardiometabolic markers. · Nutrition reviews
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.
Findings regarding the efficacy of H. sabdariffa in obesity treatment remain inconclusive [PMID:38878905].
(2022)
— Network pharmacology-based analysis of the anti-hyperglycemic active ingredients of roselle and experimental validation.
· Computers in biology and medicine
6.PMID: 38878905 (2024) — Clinical effects of Hibiscus sabdariffa Linn. on obesity treatment: A systematic review and meta-analysis of randomized controlled trials. · Complementary therapies in medicine
7.PMID: 32354172 (2020) — Organic Acids from Roselle (Hibiscus sabdariffa L.)-A Brief Review of Its Pharmacological Effects. · Biomedicines
9.PMID: 36436183 (2023) — Hibiscus sabdariffa (Roselle) calyx: a systematic and meta-analytic review of memory-enhancing, anti-neuroinflammatory and antioxidative activities. · Inflammopharmacology
10.PMID: 38024072 (2023) — Exploring the Health Benefits and Therapeutic Potential of Roselle (Hibiscus sabdariffa) in Human Studies: A Comprehensive Review. · Cureus
11.PMID: 38432993 (2024) — The Potential of Roselle (Hibiscus sabdariffa) Plant in Industrial Applications: A Promising Source of Functional Compounds. · Journal of oleo science
12.PMID: 31833112 (2020) — Effect of Hibiscus sabdariffa (Roselle) supplementation in regulating blood lipids among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis. · Phytotherapy research : PTR
13.PMID: 27186114 (2012) — Hibiscus sabdariffa L., roselle calyx, from ethnobotany to pharmacology. · Journal of experimental pharmacology
14.PMID: 40549318 (2025) — Hibiscus sabdariffa L. (Roselle flower) extract exerts protective effects against lipopolysaccharide-induced inflammation by ameliorating TLR4/NF-κB and NLRP3 inflammasome activation. · Inflammopharmacology
15.PMID: 40806423 (2025) — Hibiscus Collagen Alternative (VC-H1) as an Oral Skin Rejuvenating Agent: A 12-Week Pilot Study. · International journal of molecular sciences
16.PMID: 40009760 (2025) — Acute effects of Hibiscus sabdariffa on blood pressure and cognitive function. · Nutritional neuroscience
17.PMID: 35885378 (2022) — Hibiscus sabdariffa in Diabetes Prevention and Treatment-Does It Work? An Evidence-Based Review. · Foods (Basel, Switzerland)
18.PMID: 17995816 (2007) — Roselle (Hibiscus sabdariffa) seed oil is a rich source of gamma-tocopherol. · Journal of food science
19.PMID: 36144809 (2022) — Potential of Hibiscus sabdariffa L. and Hibiscus Acid to Reverse Skin Aging. · Molecules (Basel, Switzerland)
20.PMID: 35758855 (2022) — Improvement on blood pressure and skin using roselle drink: A clinical trial. · Journal of food biochemistry
21.PMID: 32948827 (2021) — Hypertension treatment with Combretum micranthum or Hibiscus sabdariffa, as decoction or tablet: a randomized clinical trial. · Journal of human hypertension